RRML - Diffuse large B-cell lymphoma – a new look and old prognostic factors
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- July 2024 -
 
A comprehensive review of Prof... 13
Romanian Review of Laboratory ... 7
Evaluation of routine laborato... 5
Monocyte to high-density lipop... 4
The role of nitro oxidative fa... 4
Diagnostic value of stress myo... 4
The frequency of EGFR gene mut... 4
Assessment of ocrelizumab impa... 4
Correlations of high miRNA exp... 4
The usefulness of IS6110 neste... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 20(4)/2012
XML
TXT

Diffuse large B-cell lymphoma – a new look and old prognostic factors

Camelia Dobrea, Hamed Al Salamat, Anca Roxana Lupu


Abstract:

Diffuse large B-cell lymphoma (DLBCL) accounts for about 30% of non-Hodgkin’s lymphoma (NHL) cases. The 2008 WHO Classification of Lymphoid Neoplasms recognizes several clinicopathological variants, subtypes and distinct disease entities of DLBCL. We present a review of clinical, pathological and molecular factors with implication in DLBCL behavior. Even if the golden standard therapy for CD20-positive DLBCL is still represented by R-CHOP, prognostic factor assessment could open new therapeutic perspectives.

Keywords: diffuse large B cell lymphoma,prognostic factors

 
  PDF Download full text PDF
(870 KB)
     
 
How to cite
Dobrea C, Al Salamat H, Lupu AR. Diffuse large B-cell lymphoma – a new look and old prognostic factors. Rev Romana Med Lab. 2012;20(4):307-15